SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8+ T cell activation.
Liu W, You D, Lin J, Zou H, Zhang L, Luo S, Yuan Y, Wang Z, Qi J, Wang W, Ye X, Yang X, Deng Y, Teng F, Zheng X, Lin Y, Huang Z, Huang Y, Yang Z, Zhou X, Zhang Y, Chen R, Xu L, Li J, Yang W, Zhang H.
Liu W, et al. Among authors: ye x.
Cell Metab. 2024 Aug 29:S1550-4131(24)00332-2. doi: 10.1016/j.cmet.2024.08.005. Online ahead of print.
Cell Metab. 2024.
PMID: 39243758